Chemotherapy prostate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Prostate Cell Line, Tumor Tumor Cells, Cultured Seminal Vesicles Epithelial Cells Neoplastic Stem Cells

Organisms2

Mice, Nude Mice, SCID

Diseases60

Prostatic Neoplasms Prostatic Hyperplasia Breast Neoplasms Adenocarcinoma Lung Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Neoplasms Bone Neoplasms Disease Progression Prostatic Intraepithelial Neoplasia Neoplasms, Hormone-Dependent Carcinoma Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Testicular Neoplasms Colorectal Neoplasms Neutropenia Vomiting Nausea Lymphoma, Non-Hodgkin Lymphatic Metastasis Hodgkin Disease Prostatic Diseases Neoplasm Invasiveness Brain Neoplasms Neoplasms, Germ Cell and Embryonal Recurrence Osteosarcoma Leukopenia Liver Neoplasms Stomach Neoplasms Peritoneal Neoplasms Germinoma Prostatitis Carcinoma, Squamous Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma Leukemia, Myeloid, Acute Sarcoma Thrombocytopenia Head and Neck Neoplasms Colonic Neoplasms Neoplasm, Residual Prostatic Neoplasms, Castration-Resistant Urinary Bladder Neoplasms Pancreatic Neoplasms Neoplasms, Second Primary Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Radiation Injuries Seminoma Genetic Predisposition to Disease Mediastinal Neoplasms Stomatitis Central Nervous System Neoplasms Hematologic Diseases Soft Tissue Neoplasms Neovascularization, Pathologic Rectal Neoplasms

Chemicals and Drugs84

Antineoplastic Agents Prostate-Specific Antigen Cisplatin Doxorubicin Cyclophosphamide Androgens Receptors, Androgen Etoposide Taxoids Androgen Antagonists Tumor Markers, Biological Paclitaxel Methotrexate Carboplatin Vinblastine Ifosfamide Antimetabolites, Antineoplastic Bleomycin Deoxycytidine Organoplatinum Compounds Antineoplastic Agents, Phytogenic Antineoplastic Agents, Alkylating Anthracyclines Cytarabine Antineoplastic Agents, Hormonal Antibiotics, Antineoplastic Mitoxantrone Dihydrotestosterone Dacarbazine Camptothecin Carmustine Tosyl Compounds Granulocyte Colony-Stimulating Factor Lomustine Platinum Compounds Neoplasm Proteins Melphalan Finasteride Mitomycin Antiemetics Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Thiotepa RNA, Messenger Androgen Receptor Antagonists Tegafur Bridged Compounds Daunorubicin Anilides 5-alpha Reductase Inhibitors Testosterone Receptor, erbB-2 Vindesine Platinum Flutamide Metribolone Oxonic Acid Receptors, Estrogen Estramustine Azasteroids Angiogenesis Inhibitors Glutamate Carboxypeptidase II PTEN Phosphohydrolase Antigens, Neoplasm DNA, Neoplasm Prednisolone Antibodies, Monoclonal, Murine-Derived RNA, Small Interfering Radiopharmaceuticals Tumor Suppressor Protein p53 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Cholestenone 5 alpha-Reductase Goserelin Dexamethasone Testosterone Congeners P-Glycoprotein Mesna Recombinant Proteins Proto-Oncogene Proteins c-bcl-2 Anticarcinogenic Agents Nimustine Ki-67 Antigen Glutathione S-Transferase pi Granisetron

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Neoplasm Staging Neoadjuvant Therapy Disease-Free Survival Prognosis Survival Analysis Survival Rate Prostatectomy Drug Administration Schedule Orchiectomy Transurethral Resection of Prostate Induction Chemotherapy Follow-Up Studies Radiotherapy Prospective Studies Salvage Therapy Immunohistochemistry Chemotherapy, Cancer, Regional Perfusion Radiotherapy Dosage Kaplan-Meier Estimate Radiotherapy, Adjuvant Neoplasm Grading Clinical Trials as Topic Transplantation, Autologous Risk Factors Xenograft Model Antitumor Assays Brachytherapy Multivariate Analysis Biopsy, Needle Neoplasm Transplantation Biopsy Palliative Care Randomized Controlled Trials as Topic Reverse Transcriptase Polymerase Chain Reaction Digital Rectal Examination Infusions, Intravenous Proportional Hazards Models Infusions, Intra-Arterial Predictive Value of Tests Drug Therapy Case-Control Studies Hematopoietic Stem Cell Transplantation Cohort Studies Radiotherapy, Conformal Transplantation, Heterologous Castration Feasibility Studies Tumor Burden Sensitivity and Specificity Clinical Trials, Phase III as Topic Hyperthermia, Induced Risk Assessment Gene Expression Profiling Drug Screening Assays, Antitumor Chemoradiotherapy Tomography, X-Ray Computed Radiotherapy, Intensity-Modulated Blotting, Western Maintenance Chemotherapy Pilot Projects Actuarial Analysis Incidence Dose Fractionation Treatment Failure Cranial Irradiation Administration, Oral Immunotherapy Fatal Outcome Positron-Emission Tomography Bone Marrow Transplantation Clinical Trials, Phase II as Topic Molecular Targeted Therapy Risk Reproducibility of Results SEER Program Mastectomy Magnetic Resonance Imaging Immunoenzyme Techniques

Phenomena and Processes16

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Time Factors Apoptosis Cell Proliferation Dose-Response Relationship, Drug Signal Transduction Cell Survival Sensitivity and Specificity Cell Division Drug Synergism Cell Growth Processes Down-Regulation Genetic Predisposition to Disease Risk Cell Cycle

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science6

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Incidence Fatal Outcome SEER Program

Health Care32

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Clinical Trials as Topic Risk Factors Multivariate Analysis Palliative Care Randomized Controlled Trials as Topic Proportional Hazards Models Predictive Value of Tests Case-Control Studies Cohort Studies Feasibility Studies Sensitivity and Specificity Watchful Waiting Clinical Trials, Phase III as Topic Risk Assessment Age Factors Pilot Projects Actuarial Analysis Incidence Treatment Failure Fatal Outcome Clinical Trials, Phase II as Topic Radiation Injuries Risk Reproducibility of Results SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Prostate Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Antineoplastic Agents Combined Modality Therapy Prostatic Neoplasms Prostate-Specific Antigen Cisplatin Treatment Outcome Doxorubicin Cyclophosphamide Neoplasm Staging Neoadjuvant Therapy Cell Line, Tumor Disease-Free Survival Prognosis Prostatic Hyperplasia Breast Neoplasms Adenocarcinoma Survival Analysis Androgens Receptors, Androgen Etoposide Survival Rate Lung Neoplasms Prostatectomy Drug Administration Schedule Taxoids Neoplasm Recurrence, Local Androgen Antagonists Neoplasm Metastasis Orchiectomy Tumor Markers, Biological Paclitaxel Methotrexate Neoplasms Drug Resistance, Neoplasm Carboplatin Bone Neoplasms Gene Expression Regulation, Neoplastic Vinblastine Transurethral Resection of Prostate Induction Chemotherapy Disease Progression Follow-Up Studies Prostatic Intraepithelial Neoplasia Neoplasms, Hormone-Dependent Time Factors Ifosfamide Antimetabolites, Antineoplastic Bleomycin Deoxycytidine Organoplatinum Compounds Antineoplastic Agents, Phytogenic Radiotherapy Prospective Studies Apoptosis Salvage Therapy Mice, Nude Antineoplastic Agents, Alkylating Immunohistochemistry Carcinoma Ovarian Neoplasms Tumor Cells, Cultured Anthracyclines Chemotherapy, Cancer, Regional Perfusion Cytarabine Carcinoma, Non-Small-Cell Lung Radiotherapy Dosage Testicular Neoplasms Cell Proliferation Kaplan-Meier Estimate Radiotherapy, Adjuvant Dose-Response Relationship, Drug Neoplasm Grading Colorectal Neoplasms Clinical Trials as Topic Antineoplastic Agents, Hormonal Neutropenia Vomiting Nausea Lymphoma, Non-Hodgkin Transplantation, Autologous Antibiotics, Antineoplastic Lymphatic Metastasis Risk Factors Hodgkin Disease Xenograft Model Antitumor Assays Prostatic Diseases Mitoxantrone Dihydrotestosterone Dacarbazine Brachytherapy Camptothecin Neoplasm Invasiveness Brain Neoplasms Neoplasms, Germ Cell and Embryonal Carmustine Tosyl Compounds Multivariate Analysis

No FAQ available that match "chemotherapy prostate"